---
layout: post
title: "微芯生物：西达本胺临床试验申请获批"
date: 2022-01-13 15:53:22 +0800
categories: emnews
tags: 东财滚动新闻
---
> 微芯生物公告，西达本胺联合替雷利珠单抗治疗非小细胞肺癌II期临床试验申请获得批准。（财联社）

<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.688321" data-code="688321|1|1" data-code2="688321|1|23|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.688321&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 688321_0" data-code="K 688321|1|1" data-code2="K 688321|1|23|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p><span id="stock_1.688321"><a href="http://quote.eastmoney.com/unify/r/1.688321" class="keytip" data-code="1,688321">微芯生物</a></span><span id="quote_1.688321"></span><span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>，西达本胺联合替雷利珠单抗治疗非小细胞肺癌II期临床试验申请获得批准。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finance.eastmoney.com/news/1354,202201132246839742.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)